Skip to Content

Join the 'Tacrolimus' group to help and get support from people like you.

Tacrolimus News

Related terms: Tacrolimus Topical

Study Suggests Causes for Lupus' Impact on Immune System

Posted 8 Mar 2016 by Drugs.com

TUESDAY, March 8, 2016 – Scientists have found new clues that help explain what's going wrong in the immune systems of people with lupus – insight they hope will lead to new therapies, or help guide current treatment choices. Lupus has several forms, but the most common is systemic lupus erythematosus (SLE). In SLE, the immune system mistakenly produces antibodies against the body's own tissue. ...

FDA Approves Envarsus XR (tacrolimus) for Prevention of Organ Rejection in Kidney Transplant Patients

Posted 24 Jul 2015 by Drugs.com

Hørsholm, Denmark, July 10, 2015 – Veloxis Pharmaceuticals A/S (OMX: VELO) today announced U.S. Food and Drug Administration (FDA) approval of Envarsus XR (tacrolimus extended-release tablets) for the prophylaxis of rejection in kidney transplant patients who require or desire conversion from other twice-daily tacrolimus products to once-daily Envarsus XR. Veloxis expects Envarsus XR to be ...

New Technique Protects Tissue Transplant From Rejection: Study

Posted 13 Aug 2014 by Drugs.com

WEDNESDAY, Aug. 13, 2014 – A new technique for delivering anti-rejection drugs directly to the site of a tissue graft transplant is effective, lasts for months and is safer than drugs that suppress the entire immune system, a new study indicates. After a patient receives a tissue graft transplant – typically on the hand, arm, leg or face – they start taking drugs to prevent their immune system ...

Astellas Announces FDA Approval of Astagraf XL (tacrolimus extended-release capsules) for the Prophylaxis of Organ Rejection

Posted 22 Jul 2013 by Drugs.com

NORTHBROOK, Ill., July 19, 2013 /PRNewswire/ – Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved Astagraf XL (tacrolimus extended-release capsules) for the prophylaxis of organ rejection in patients receiving a kidney transplant with mycophenolate mofetil (MMF) and ...

Ask a Question

Further Information

Related Condition Support Groups

Organ Transplant - Rejection Prophylaxis, Organ Transplant - Rejection Reversal, Crohn's Disease, Graft-versus-host disease

Related Drug Support Groups

Prograf, Envarsus XR, Astagraf XL, Hecoria

Tacrolimus Patient Information at Drugs.com